| Post-hospitalization follow-up | N = 374 | % |
| Consultations | ||
| Regular | 41 | 10.9 |
| Irregular | 53 | 14.1 |
| Poor compliants | 280 | 74.8 |
| Attending physician | ||
| Usual practitioner | 41 | 10.9 |
| Others | 53 | 14.1 |
| Titration sessions | ||
| Reaching the target dose | ||
| Reaching the target dose | 40 | 10.7 |
| ARBs | 6 | 1.6 |
| Beta blockers | 34 | 9.1 |
| Stationary dose | ||
| ACE Inhibitors | 15 | 4 |
| ARBs | 2 | 0.5 |
| Beta blockers | 7 | 1.9 |
| Cardiovascular rehabilitation | ||
| Therapeutic education | 74 | 19.4 |
| Exercise training | 20 | 5.3 |
| Paraclinical control balance sheet | ||
| ECG | 14 | 3.7 |
| Cardiac X-ray | 5 | 1.3 |
| Echocardiography | 25 | 6.7 |
| Outcome at 2 years follow-up | ||
| Rehospitalizations | 185 | 49.5 |
| Death | 113 | 30.2 |